Literature DB >> 29673706

Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway.

Chunyan Feng1, Bin Lou1, Jibin Dong1, Zhiqiang Li2, Yunqin Chen3, Yue Li1, Xuemei Zhang1, Xian-Cheng Jiang4, Tingbo Ding5.   

Abstract

Levels of polyunsaturated phosphatidylcholine (PC) influence plasma membrane structure and function. Phosphatidylcholine (PC) is synthesized de novo in the Kennedy pathway and then undergoes extensive deacylation/reacylation remodeling via Lands' cycle (non-Kennedy pathway). The reacylation is catalyzed by lysophosphatidylcholine acyltransferase (LPCAT), which adds a polyunsaturated fatty acid at the sn-2 position. Four LPCAT isoforms have been described to date, among which we found LPCAT3 to be the major isoform in adipose tissue, but its exact role in adipogenesis is unclear. In this study, we aimed to investigate whether LPCAT3 activity affects 3T3L1 cell adipogenic differentiation potential and its underline mechanism. Lentivirus-mediated LPCAT3 shRNA expression stably knocked down LPCAT3 in 3T3L1 preadipocytes and LPCAT3 deficiency dramatically reduced the levels of cellular polyunsaturated PCs. Importantly, we found that this deficiency activated the β-catenin dependent Wnt signaling pathway, which suppressed the expression of adipogenesis-related genes, thereby inhibiting 3T3L1 preadipocyte differentiation and lipid accumulation. Moreover, three different Wnt/β-catenin pathway inhibitors reversed the effect of LPCAP3 deficiency, suggesting that Wnt/β-catenin pathway activation is one of the causes for the observed phenotypes. To the best of our knowledge, we show here for the first time that PC remodeling is an important regulator of adipocyte differentiation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3T3L1 adipocytes; Adipogenesis; Lipogenesis; Lysophosphatidylcholine acyltransferase 3 gene knockdown; Phosphatidylcholine remodeling; Wnt/β-catenin pathway

Mesh:

Substances:

Year:  2018        PMID: 29673706      PMCID: PMC8006744          DOI: 10.1016/j.bbalip.2018.04.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  47 in total

Review 1.  Transcriptional regulation of adipogenesis.

Authors:  E D Rosen; C J Walkey; P Puigserver; B M Spiegelman
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

2.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

3.  Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity.

Authors:  Célia Sousa; Cláudia Nunes; Marlene Lúcio; Helena Ferreira; José L F C Lima; Joana Tavares; Anabela Cordeiro-da-Silva; Salette Reis
Journal:  J Pharm Sci       Date:  2008-08       Impact factor: 3.534

4.  Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha.

Authors:  Masanobu Kawai; Sotaro Mushiake; Kazuhiko Bessho; Mari Murakami; Noriyuki Namba; Chikara Kokubu; Toshimi Michigami; Keiichi Ozono
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

Review 5.  Current methods of adipogenic differentiation of mesenchymal stem cells.

Authors:  Michelle A Scott; Virginia T Nguyen; Benjamin Levi; Aaron W James
Journal:  Stem Cells Dev       Date:  2011-06-20       Impact factor: 3.272

Review 6.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function.

Authors:  C D Stubbs; A D Smith
Journal:  Biochim Biophys Acta       Date:  1984-01-27

Review 7.  New developments in adipogenesis.

Authors:  Martina I Lefterova; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2009-03-09       Impact factor: 12.015

8.  Lypd6 enhances Wnt/β-catenin signaling by promoting Lrp6 phosphorylation in raft plasma membrane domains.

Authors:  Günes Özhan; Erdinc Sezgin; Daniel Wehner; Astrid S Pfister; Susanne J Kühl; Birgit Kagermeier-Schenk; Michael Kühl; Petra Schwille; Gilbert Weidinger
Journal:  Dev Cell       Date:  2013-08-26       Impact factor: 12.270

9.  Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins.

Authors:  W C Yeh; Z Cao; M Classon; S L McKnight
Journal:  Genes Dev       Date:  1995-01-15       Impact factor: 11.361

10.  Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.

Authors:  Xin Rong; Bo Wang; Merlow M Dunham; Per Niklas Hedde; Jinny S Wong; Enrico Gratton; Stephen G Young; David A Ford; Peter Tontonoz
Journal:  Elife       Date:  2015-03-25       Impact factor: 8.140

View more
  5 in total

Review 1.  Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer.

Authors:  Gaoxuan Shao; Yufan Qian; Lu Lu; Ying Liu; Tao Wu; Guang Ji; Hanchen Xu
Journal:  J Cancer       Date:  2022-05-01       Impact factor: 4.478

Review 2.  Phospholipid Remodeling in Physiology and Disease.

Authors:  Bo Wang; Peter Tontonoz
Journal:  Annu Rev Physiol       Date:  2018-10-31       Impact factor: 19.318

3.  The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3.

Authors:  Qing Zhang; Deqiang Yao; Bing Rao; Liyan Jian; Yang Chen; Kexin Hu; Ying Xia; Shaobai Li; Yafeng Shen; An Qin; Jie Zhao; Lu Zhou; Ming Lei; Xian-Cheng Jiang; Yu Cao
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

Review 4.  Roles of polyunsaturated fatty acids, from mediators to membranes.

Authors:  Takeshi Harayama; Takao Shimizu
Journal:  J Lipid Res       Date:  2020-06-02       Impact factor: 5.922

5.  A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.

Authors:  Xinming Du; Jiachun Hu; Qing Zhang; Qi Liu; Xinxin Xiang; Jibin Dong; Bin Lou; Shuhua He; Xiang Gu; Yu Cao; Yingxia Li; Tingbo Ding
Journal:  FEBS Open Bio       Date:  2019-08-30       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.